Q4 2024 Medicover AB Earnings Call Transcript
Key Points
- Medicover AB (LTS:0RPS) reported strong double-digit organic growth in both healthcare services and diagnostic services divisions.
- The company achieved significant margin expansion, with EBITDA margins improving by 30 to 110 basis points across various metrics.
- Net operating cash flow increased by more than 50% compared to the previous year, indicating strong cash generation.
- Poland and Germany showed robust performance, contributing significantly to revenue growth and margin expansion.
- The board proposed a 25% increase in dividends, reflecting confidence in the company's financial position and future outlook.
- India's organic growth was lower than local peers, with expectations for acceleration in 2025.
- The company faces challenges in the German market due to no price adjustments in public revenue despite cost inflation.
- Central costs increased significantly, partly due to IFRS2 costs being accounted for centrally.
- The occupancy rate in Indian hospitals is around 50%, which is lower than industry benchmarks.
- There is uncertainty regarding the timeline and execution of the potential listing of the Indian subsidiary.
Go ahead.
So, good morning everyone. Welcome to Medicover's 4th quarter 2024 and full year 2024 reporting.
I have with me in the room Anan Patel. I have also with me in the room John Stubbington and I start with saying you also saw this announcement in the morning, that John will be succeeding me as CEO May 1 and we will comment on that towards the end of the presentation as well as take any questions related to that during the Q&A when of course John will also be able to answer any questions.
So the highlights for the quarter. I think we've had a number of very strong quarters that we have reported throughout 2024 and I think this is the same. I think it's an excellent quarter to end 2024 with. We have double digit volume growth in both divisions both reporting segment and that is then topped up with significant pricing power in both divisions. So, a very high double digit organic growth in both divisions and for the group.
And in addition to that, both reporting segments, both divisions we see
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
